This issue of the magazine takes us to to the frontiers of bioinformatics and the applications that will make precision medicine a reality
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
Boston-based startup Veritas Genetics emerge from Series B funding round $30 million richer, to expand operations around the world
Analysis company Genomics plc appointed as Analysis Partner for the Genomics England Genomics Expert Network for Enterprises (GENE) Consortium
New course from the Wellcome Genome Campus aims to bridge the gap between academic innovation in genomics, and commercial success
Congenica’s role in developing genomic diagnostics has been recognised by the life sciences industry in the prestigious OBN Awards.
Theranos pivot from consumer-focused blood testing to bringing miniLab platform to hospitals
New episode of Signal podcast calls shenanigans on the tactics that drug companies use to stay ahead in the market
Color Genomics announce investment round of $45M led by General Catalyst with participation from the U2 front man
Straight out of San Diego, California, comes next-generation mapping for structural variations in the genome